Get the latest news and trends on Long Island companies and the people behind them.
Schein to acquire stake in implant maker
Health care product giant Henry Schein Inc. Tuesday took another bite into the dental market with a deal to take a majority stake in an Birmingham, Ala., maker of implants.
Financial terms of the deal with BioHorizons, which generates about $115 million in annual revenue, were not disclosed.
Under the agreement, Melville-based Schein would loan $145 million to BioHorizons to fund a distribution to shareholders followed by an equity investment for 60 percent of the company’s shares. BioHorizons will continue to operate as a separate company.
The deal fits Schein’s strategy of expanding its dental business and Baird Equity Research analyst Jeff Johnson estimated that the transaction would make Schein the world’s No. 5 dental implant maker.
In a statement, Schein said it expects the deal to trim earning per share in 2014 by 3 to 5 cents, but add 3 to 4 cents in 2015.
Don’t expect the deal to be Schein’s last, one analyst said.
ISI Group analyst Michael Cherny said he expects Schein “to maintain a steady pace of M & A” in all its lines.